Sign Out
Clear to opalescent, colourless to slightly yellow, pH 5.9 solution.
Each mL of concentrate for solution for infusion contains 150 mg of anifrolumab.
One vial of 2.0 mL of concentrate contains 300 mg of anifrolumab (150 mg/mL).
Anifrolumab is a human, immunoglobulin G1 kappa (IgG1κ) monoclonal antibody produced in mouse myeloma cells (NS0) by recombinant DNA technology.
Excipients/Inactive Ingredients: Histidine, Histidine hydrochloride monohydrate, Lysine hydrochloride, Trehalose dihydrate, Polysorbate 80, Water for injections.
Continue with Google